FKBP12.6 disruption impairs glucose-induced insulin secretion |
| |
Authors: | Noguchi Naoya Yoshikawa Takeo Ikeda Takayuki Takahashi Iwao Shervani Nausheen Jamal Uruno Akira Yamauchi Akiyo Nata Koji Takasawa Shin Okamoto Hiroshi Sugawara Akira |
| |
Affiliation: | a Department of Advanced Biological Sciences for Regeneration (Kotobiken Medical Laboratories), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Sendai 980-8575, Japan b Department of Biochemistry, Nara Medical University, Kashihara 634-8521, Japan c Department of Medical Biochemistry, Iwate Medical University School of Pharmacy, Yahaba-cho 028-3603, Japan |
| |
Abstract: | Cyclic ADP-ribose (cADPR), accumulated in pancreatic β-cells in response to elevated ATP levels after glucose stimulation, mobilizes Ca2+ from the endoplasmic reticulum through the ryanodine receptor (RyR) and thereby induces insulin secretion. We have recently demonstrated in an in vitro study that cADPR activates RyR through binding to FK506-binding protein 12.6 (FKBP12.6), an accessory protein of RyR. Here we generated FKBP12.6-deficient (FKBP12.6−/−) mice by homologous recombination. FKBP12.6−/− mice showed glucose intolerance coupled to insufficient insulin secretion upon a glucose challenge. Insulin secretion in response to glucose was markedly impaired in FKBP12.6−/− islets, while sulfonylurea- or KCl-induced insulin secretion was unaffected. No difference was found in the glucose oxidation rate between FKBP12.6−/− and wild-type islets. These results indicate that FKBP12.6 plays a role in glucose-induced insulin secretion downstream of ATP production, independently of ATP-sensitive K+ channels, in pancreatic β-cells. |
| |
Keywords: | FKBP12.6, FK506-binding protein 12.6 cADPR, cyclic ADP-ribose RyR, ryanodine receptor |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|